year, representing a seven-year high and it remains a driving force of the economy this year according to the Bank of Thailand. GDP has again been upgraded from 3.8-4% to 4-4.5% which is positive for the
according to the percentage of its shareholding in full year which was amount by 61.89 million, increased from amount by 42.43 million of previous year by 45.8 percent. The increased was due mainly to the
quarter expanded by 4.8%, higher than 3.9% growth in the previous quarter, according to data from Bank of Thailand and NESDB. This was mainly from acceleration of private consumption, government consumption
million according to Labor Protection Laws as TAS no.19 on employee benefits. 2.3 Shareholders’ Equity As at June 30, 2018, total shareholders’ equity was of Bt7,505.6 million, decreased from December 31
recorded an increased revenue coinciding with global crude oil price, leading to increased gross profit, but saw production and sales volume decrease according to the Natural Decline Curve. There was also
subsidiaries recognized profit sharing to minority shareholders according to the percentage of shareholding of net profit in subsidiary was amount by 13.59 million for the three month period ended 30th June 2018
granted a license from China Food and Drug Administration (CFDA) during the beginning of 2018 as the Company had to redesign and adjust product packaging according to the granted license as well as change
According to the Bank of Thailand and Office of the National Economic and Social Development Board data, the Thai economy in the second quarter of 2018 expanded by 4.6%, decreased from 4.8% in the previous
same period last year. This figure shows that the Company significantly cut on sales expenses from the previous year according to the drop in sales revenue. However, sales expenses to sales revenue ratio